AIM

#4754
AIM ImmunoTech Inc. Common Stock
0.3 9 USD
-7.14%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
0.39
0.39
Yıllık Aralık
0.21
20.35
Günlük Değişim
-7.14%
Aylık Değişim
-23.54%
6 Aylık Değişim
-75.65%
Yıllık Değişim
-95.41%
Önceki Kapanış
0.4 2
Open
0.3 9
Düşük
0.3 9
High
0.3 9
Hacim
233
Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler
Çeyreklik Yıllık
Gelir tablosu Bilanço Nakit akışı
Değer 202020212022202320242025 TTM

AIM ImmunoTech Inc. Common Stock

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Haberler